Cardiometabolic Profiles of Boys With Klinefelter Syndrome
NCT02723305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2022-03-08
Summary
This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such as diabetes, extra weight gain, heart disease and liver diseases.
Conditions
- Klinefelter Syndrome
- 47,XXY
- Sex Chromosome Aneuploidy
- XXY Syndrome
Interventions
- OTHER
-
No intervention
Sponsors & Collaborators
-
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Shanlee M Davis, MD · University of Colorado/Children's Hospital Colorado
Eligibility
- Min Age
- 12 Years
- Max Age
- 17 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY
NCT03325647 ·Status: COMPLETED ·Phase: PHASE4
-
Turner And Klinefelter Treatment Target Study
NCT04803474 ·Status: UNKNOWN
-
Human Chorionic Gonadotropin Stimulation Effects on Steroidogenesis in Men With Klinefelter Syndrome
NCT02788136 ·Status: COMPLETED ·Phase: NA
-
Thrombosis and Neurocognition in Klinefelter Syndrome
NCT02526628 ·Status: COMPLETED
-
Androgen Effect on Klinefelter Syndrome Motor Outcome
NCT00348946 ·Status: COMPLETED ·Phase: PHASE2
-
Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth
NCT02550431 ·Status: COMPLETED
-
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518 ·Status: TERMINATED ·Phase: PHASE2
-
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
NCT05773183 ·Status: UNKNOWN
-
CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men
NCT00729859 ·Status: COMPLETED ·Phase: PHASE2
-
Pubertal Blockade and Hormone Therapy in Transgender Youth
NCT03557268 ·Status: COMPLETED
-
Testosterone Treatment in Men With Chronic Kidney Disease
NCT05249634 ·Status: RECRUITING ·Phase: PHASE2
-
Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome
NCT00134745 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Outcomes of Low Testosterone
NCT02758431 ·Status: COMPLETED ·Phase: NA
-
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
NCT01215292 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testosterone Administration and ACL Reconstruction in Men
NCT01595581 ·Status: COMPLETED ·Phase: PHASE3
-
Expanded Access for Lorenzo's Oil (GTO/GTE) in Adrenoleukodystrophy
NCT02233257 ·Status: NO_LONGER_AVAILABLE
-
Cardiometabolic Health in Transgender Males
NCT04977765 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Normal and IHH Men
NCT00470990 ·Status: COMPLETED ·Phase: NA
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Growing up With the Young Endocrine Support System (YESS!)
NCT04252001 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
NCT06689085 ·Status: RECRUITING ·Phase: PHASE3
-
Autonomic Manifestations of Testosterone Deficiency in Men
NCT02715713 ·Status: WITHDRAWN
-
Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes
NCT00529230 ·Status: TERMINATED
-
Impaired HDL and Coronary Artery Disease in Anabolic Androgenic Steroid Users
NCT03450837 ·Status: COMPLETED
-
Effect of Hormone Therapy on Renal Function
NCT04482920 ·Status: COMPLETED